Due to the Excellence trial expansion and positive Avatar data (assuming positive), I’m hoping Anavex has taken an interim peak of the original 64 Excellence patients, to see if they can show significant data across the entire patient population, regardless of subset analysis. If something like this happened hopefully we see an Excellence update on clinical trials website in the coming days/weeks. Fingers crossed.
News 
Market Data 
Discover 
